Determined cyclists rally for Ride’s 10th edition
Ten years after its debut, the Enbridge Ride to Conquer Cancer reached its landmark anniversary on July 7 and 8, with 1,308 participants raising more than $4.8 million for the Segal Cancer Centre and its partners across Quebec.
Cyclists on Cloud 9 after raising $4.1 million to fight cancer
After a demanding, 200-kilometre ride from Montreal to Quebec City, 1,100 cyclists in the 9th annual Enbridge Ride to Conquer Cancer raised $4.1 million for the JGH and its partners across Quebec.
Promising therapy for relapsed patients with aggressive form of lymphoma
A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.
Segal Cancer Centre joins the “Cancer Moonshot”
The Segal Cancer Centre is taking “one small step” that could lead to “one giant leap” in a metaphorical moonshot to conquer cancer.
Easing cancer survivors back into the work force
You’ve waged a tough battle against cancer—and you’ve won. Congratulations! But what happens now that you’re ready to go back to work?
Congratulations
In the space of just a few months this past spring, Dr. Gerald Batist was appointed a Member of the Order of Canada and a Knight of the National Order of Quebec.
JGH praised for attention to needs of young adults with cancer
The Segal Cancer Centre at the JGH has distinguished itself as the only medical centre in Quebec to serve the needs of adolescents and young adults with cancer by providing a dedicated clinic staffed by a multi-disciplinary team.
Eight is great for cyclists in anti-cancer ride
A determined legion of 1,222 cyclists powered their way from Montreal to Quebec City on July 9 and 10 to raise a remarkable $4.4 million in the eighth annual Enbridge Ride to Conquer Cancer.
Bone health assumes key importance in breast cancer recovery
One of Hope & Cope’s newest initiatives, the Breast & Bone Health Program, identifies women who have had breast cancer and are at risk for bone fragility.
Landmark clinical trial under way for type 1 diabetes treatment
Patients with long-standing type 1 diabetes are undergoing a clinical trial for a therapeutic approach that combines an agent for stimulating the growth of insulin-secreting cells in the pancreas, along with a drug to prevent the autoimmune system from rejecting the newly formed cells.